Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Okamoto

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 3, 2014
Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometryMikio Maruwaka, Kazuhiro Yoshikawa, Sho Okamoto, et al.
World Neurosurgery|February 13, 2018
Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya DiseaseShinsuke Muraoka, Yoshio Araki, Goro Kondo, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 28, 2015
Treatment of Symptomatic Bilateral Cavernous Carotid Aneurysms: Long-term Results of 6 CasesYoichi Uozumi, Sho Okamoto, Yoshio Araki, et al.
NMC Case Report Journal|January 26, 2022
Coexistence of a Dural Arteriovenous Fistula and Pial Arteriovenous Malformation Sharing a Common DrainerKenji Uda, Takashi Izumi, Fumiaki Kanamori, et al.
Hematology (Amsterdam, Netherlands)|November 3, 2022
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemiaHiroshi Ureshino, Kazuharu Kamachi, Haruhiko Sano, et al.
Acta Neurochirurgica|January 6, 2021
Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya diseaseFumiaki Kanamori, Yoshio Araki, Kinya Yokoyama, et al.
Hematological Oncology|June 12, 2021
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experienceHiroshi Ureshino, Kazuharu Kamachi, Atsujiro Nishioka, et al.
Acta Neurochirurgica|February 24, 2021
Ipsilateral late stroke after revascularization surgery for patients with Moyamoya diseaseYoshio Araki, Kinya Yokoyama, Kenji Uda, et al.
World Neurosurgery|June 5, 2018
Prediction of Intracranial Arterial Stenosis Progression in Patients with Moyamoya Vasculopathy: Contrast-Enhanced High-Resolution Magnetic Resonance Vessel Wall ImagingShinsuke Muraoka, Yoshio Araki, Toshiaki Taoka, et al.
Nagoya Journal of Medical Science|September 23, 2021
<Editors' Choice> Indocyanine green emission timing of the recipient artery in revascularization surgery for moyamoya diseaseFumiaki Kanamori, Yoshio Araki, Kinya Yokoyama, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 3, 2014
Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometryMikio Maruwaka, Kazuhiro Yoshikawa, Sho Okamoto, et al.
World Neurosurgery|February 13, 2018
Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya DiseaseShinsuke Muraoka, Yoshio Araki, Goro Kondo, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 28, 2015
Treatment of Symptomatic Bilateral Cavernous Carotid Aneurysms: Long-term Results of 6 CasesYoichi Uozumi, Sho Okamoto, Yoshio Araki, et al.
NMC Case Report Journal|January 26, 2022
Coexistence of a Dural Arteriovenous Fistula and Pial Arteriovenous Malformation Sharing a Common DrainerKenji Uda, Takashi Izumi, Fumiaki Kanamori, et al.
Hematology (Amsterdam, Netherlands)|November 3, 2022
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemiaHiroshi Ureshino, Kazuharu Kamachi, Haruhiko Sano, et al.
Acta Neurochirurgica|January 6, 2021
Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya diseaseFumiaki Kanamori, Yoshio Araki, Kinya Yokoyama, et al.
Hematological Oncology|June 12, 2021
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experienceHiroshi Ureshino, Kazuharu Kamachi, Atsujiro Nishioka, et al.
Acta Neurochirurgica|February 24, 2021
Ipsilateral late stroke after revascularization surgery for patients with Moyamoya diseaseYoshio Araki, Kinya Yokoyama, Kenji Uda, et al.
World Neurosurgery|June 5, 2018
Prediction of Intracranial Arterial Stenosis Progression in Patients with Moyamoya Vasculopathy: Contrast-Enhanced High-Resolution Magnetic Resonance Vessel Wall ImagingShinsuke Muraoka, Yoshio Araki, Toshiaki Taoka, et al.
Nagoya Journal of Medical Science|September 23, 2021
<Editors' Choice> Indocyanine green emission timing of the recipient artery in revascularization surgery for moyamoya diseaseFumiaki Kanamori, Yoshio Araki, Kinya Yokoyama, et al.
Pageof 7